New registry to monitor safety of LOBO device in bleeding emergencies

NCT ID NCT07525518

First seen Jun 27, 2026 · Last updated Jul 22, 2026 · Updated 2 times

Summary

This registry will follow 500 adults who receive the LOBO Vascular Occlusion System, a device used to block blood vessels in cases of arterial bleeding or other conditions. The goal is to see how safe and effective the device is in everyday medical practice. Participants are enrolled after treatment, and the study will track device-related complications and how well the device stops bleeding.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
LOBO Vascular Occlusion System (a device used to block blood vessels)
What this could lead to
If successful, this registry will provide real-world data on how well the LOBO device works and its safety, helping doctors make better treatment decisions.
What could go wrong
This is an observational registry, not a controlled trial, so it cannot prove cause and effect. Results may be limited by patient selection and lack of a comparison group.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTERIAL BLEED are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

arteriovenous hemangioma/malformation Hemorrhage Pulmonary Arteriovenous Fistulas

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Charlotte Radiology

    Charlotte, North Carolina, 28202, United States

  • UMASS Chan Medical School

    Worcester, Massachusetts, 01655, United States

  • University of Colorado

    Aurora, Colorado, 80045, United States

  • University of North Carolina at Chapel Hill

    Chapel Hill, North Carolina, 27599, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.